Next Article in Journal
Preliminary Insights on Barriers to and Facilitators of Healthy Eating for Rural Residents Emerging from Extreme Poverty: A Qualitative Study in Dafang, China
Previous Article in Journal
Knowledge and Practice of Foot Care among Patients with Diabetes Attending Diabetes Center, Saudi Arabia
Previous Article in Special Issue
Central Sensitization-Related Symptoms and Influencing Factors on Health-Related Quality of Life among Frail Older Adults in Senior Day Care Centers: A Cross-Sectional Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Association between Subjective Cognitive Complaints and Sleep Disturbance among Community-Dwelling Elderly Individuals in Japan

1
Hokuriku University Well-Being Research Team, Department of Physical Therapy, Faculty of Health and Medical Science, Hokuriku University, Kanazawa 920-1180, Japan
2
Department of Physical Therapy, Faculty of Health Sciences, Kyoto Tachibana University, Kyoto 607-8175, Japan
3
Faculty of Allied Health Sciences, Kansai University of Welfare Sciences, Kashiwara 582-0026, Japan
4
Kusukinomori Co., Ltd., Imari 848-0027, Japan
*
Author to whom correspondence should be addressed.
Healthcare 2024, 12(13), 1245; https://doi.org/10.3390/healthcare12131245
Submission received: 25 April 2024 / Revised: 23 May 2024 / Accepted: 21 June 2024 / Published: 22 June 2024
(This article belongs to the Collection Health Care and Services for Elderly Population)

Abstract

:
Subjective cognitive complaints (SCCs) are a crucial modifiable risk factor for dementia. There is increasing interest in the association between SCC and sleep disturbance; however, the effects of sleep disturbance on SCC development among community-dwelling elderly individuals in Japan remain unclear. We aimed to cross-sectionally investigate the association between SCC and sleep disturbance, with adjustment for multiple factors related to cognitive decline, among 241 community-dwelling elderly persons without cognitive impairment. The measures were SCCs (Kihon Checklist-Cognitive Function, KCL-CF), sleep disturbance (Japanese version of the Athens Insomnia Scale, AIS-J), general cognitive function (Mini-Mental State Examination), and depressive symptoms (five-item version of the Geriatric Depression Scale [GDS-5]). The following data were collected: sex, age, educational history, whether the participants had visited a medical institution for diseases (hypertension, diabetes, hyperlipidemia, heart disease), and the presence/absence of established risk factors (hearing loss, history of head injury, drinking habits, smoking habits, social isolation, and physical inactivity and activity). Based on the KCL-CF, 96 and 145 participants were considered to have and lack SCCs, respectively. On logistic regression analysis, the AIS-J score and smoking history were significantly associated with SCCs. Our findings suggest that sleep disturbance is associated with SCC development among community-dwelling elderly people in Japan. Evaluating and managing sleep disturbances can be important in preventing SCCs and dementia.

1. Introduction

With population aging, dementia has become a major public health concern [1]. The global prevalence of dementia is projected to nearly triple in the coming decades, with an estimated 150 million individuals affected by 2050 [2]. Dementia imposes a huge burden on individuals, families, and society as a whole [3]. Currently, dementia remains an incurable disease; accordingly, early interventions for preventing the onset of dementia are crucial [4].
Alzheimer’s disease (AD) is the leading cause of dementia, accounting for 60–80% of all dementia cases [5]. According to a proposed framework, the stages of dementia begin with a healthy state, progressing to subjective cognitive complaints (SCCs) as a preclinical sign, mild cognitive impairment (MCI), and finally AD [6]. SCCs encompass daily memory issues and related cognitive concerns expressed by individuals, regardless of the presence of objective evidence of cognitive impairment; they are common across all age demographics [7]. However, SCCs strongly influence the development of MCI [8] and AD [9]. Moreover, pathological changes in brain tissue begin during the SCC stage, decades prior to AD onset [10,11]. Accordingly, establishing preventive and therapeutic interventions focusing on SCCs is imperative for delaying the onset of dementia in the future [12].
Several risk factors at various life stages exist for dementia development and addressing these modifiable risk factors is important to prevent dementia onset [13]. Recently, sleep disturbance has been highlighted as among the modifiable risk factors for dementia development [14]. Sleep is crucially involved in brain function and health; accordingly, sleep insufficiency or impairment can lead to various cognitive problems [15]. To this point, sleep problems may influence the development of AD [16], MCI [17], and SCCs [18].
However, studies on the association between sleep and SCCs in Japan remain limited [19]. Additionally, regional and racial differences in SCC onset may exist [20]. Thus, elucidating the impact of sleep on SCC development in the Japanese population is important. Furthermore, previous Japanese studies have failed to appropriately adjust for multiple factors associated with dementia development, which compromises the reliability of their findings. Therefore, we aimed to examine the influence of sleep disturbances on SCC development among community-dwelling elderly people in Japan, with adjustment for multiple factors related to cognitive decline. Our findings could inform the early detection of the risk of SCC development and the establishment of preventive measures and intervention programs against the future onset of dementia.

2. Materials and Methods

This cross-sectional survey of community-dwelling elderly people living in Japan was conducted between September 2021 and September 2022. Participants were recruited through flyers distributed annually from June to August in Imari City, Saga Prefecture between 2021 and 2022. These flyers clearly indicated that participation was unpaid. Data regarding the participants’ sex, age, and body mass index (BMI) were collected. Moreover, the participants underwent the Mini-Mental State Examination (MMSE) as a test of general cognitive function. The eligibility criteria for this study were as follows: no previous participation in this study; age ≥65 years; and the absence of cognitive decline, with an MMSE score ≥ 24 [21]. Meanwhile, those with a history of psychiatric or cerebrovascular disease and those who were incapable of completing all the measurement items were excluded.
Finally, this study included 241 participants (39 males and 202 females; mean age, 77.3 ± 5.9 years) (Figure 1). Written informed consent was obtained from each participant prior to participation. This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Kyoto Tachibana University (accession nos. 18–26).
In addition to general cognitive function, several other parameters were assessed. SCCs were assessed using the Kihon Checklist-Cognitive Function (KCL-CF). The severity of insomnia symptoms was assessed using the Japanese version of the Athens Insomnia Scale (AIS-J). The severity of depressive symptoms was assessed using the five-item version of the Geriatric Depression Scale (GDS-5). Moreover, the researcher conducted an oral interview with the participants regarding the presence or absence of risk factors for the development of dementia.

2.1. General Cognitive Functioning (MMSE)

General cognitive function was assessed using the MMSE [22], which is a short test that is widely used to assess cognitive function. This screening tool, which covers 11 domains including attention, executive functioning, agnosia, language, memory, orientation, praxis, prosody, thought content, thought processes, and visuospatial proficiency, has been shown to be effective [23] and reliable [21]. The participants’ cognitive performance was evaluated based on the total MMSE scores (range: 0–30), which covered all the domains measured.

2.2. SCC (KCL-CF)

The SCC status was ascertained through an interview. The participants were asked three questions that comprised the cognitive function domain of the KCL-CF, which is a self-report questionnaire designed to assess frailty that has established validity [24,25] and reliability [26]. These questions included “Do your family or your friends point out your memory loss?”, “Do you make a call by looking up phone numbers?”, and “Do you find yourself not knowing today’s date? [26]”. The KCL-CF has been previously used as a measure of subjective memory complaints [27] and self-reported cognitive decline [28]. However, we used the KCL-CF as a measure of the participants’ SCC status [29]. Each positive response (i.e., a response suggestive of SCCs) was assigned 1 point, a KCL-CF score (range: 0–3) was calculated, and the participants with a KCL-CF score ≥ 1 were considered to have SCCs [29].

2.3. Insomnia Symptoms (AIS-J)

The severity of insomnia symptoms was assessed using the AIS-J [30]. The AIS-J comprises eight items assessing insomnia symptoms within the past month (including (1) sleep initiation; (2) awakening during the night; (3) early morning awakening; (4) total sleep duration; (5) overall quality of life; (6) problems with sense of well-being; (7) overall functioning; and (8) daytime sleepiness). Each AIS-J item is rated on a four-point scale (0 = no problems at all; 1 = some problems; 2 = significant problems; 3 = very significant problems), with a higher total score (range: 0–24) indicating more severe insomnia. Based on the AIS-J score, the severity of insomnia was classified as pathological insomnia (6–24), nocturnal insomnia (4–5), and no insomnia (0–3). The validity [30] and reliability [31] of the AIS-J have already been reported.

2.4. Depressive Symptoms (GDS-5)

Depressive symptoms were assessed using the GDS-5 (a simplified version of the GDS [32]). This is a self-reported screening questionnaire designed to focus on the characteristic manifestations of depressive symptoms in the elderly population. This tool has been shown to be valid and reliable [33]. The GDS-5 comprises five questions [32], including (1) Are you satisfied with your life?; (2) Do you often get bored?; (3) Do you often feel helpless?; (4) Do you prefer to stay at home, rather than going out and doing new things?; and (5) Do you feel pretty worthless the way you are now?, which are answered on a yes/no basis. Each positive response (i.e., indicating depressive symptoms) receives one point, with the total score of all the items (range: 0–5) indicating the overall symptom severity.

2.5. Risk Factors for Dementia Development

We performed interviews for the following risk factors for developing dementia: sex [34]; age [35]; educational level [36]; a history of hypertension [37], diabetes [38], hyperlipidemia [39], and cardiovascular disease [40]; the presence of known risk factors such as hearing loss [41], a history of a head injury [42], past or current alcoholic drinking habits [43], and past or current smoking habits [44]; social isolation (no individual to interact with (in person, by phone, or through email) at least once per week [except for family members who live with you]) [45]; and physical inactivity (not exercising for ≥30 min a day, 2 days a week for at least 1 year [46]).

2.6. Sample Size Calculation

The sample size was calculated using G*Power software version 3.1.9.7. Based on a previous report [19], the prevalence of SCCs in the group with sleep disturbances was estimated to be 63%. Based on the statistical power of 80% and a level of significance set at 5%, we calculated the total sample size to be 193 participants. The sample size was increased by 67% to 323 patients to account for loss to the adaptation of the exclusion criteria.

2.7. Statistical Analysis

First, we checked the distribution normality of all the demographic and rating variables using the Shapiro–Wilk test. Next, the variables were compared between the participants with and without SCCs using the independent samples t-test (age), the Mann–Whitney U test (BMI, educational history, AIS-J, GDS-5, and MMSE), Fisher’s exact test (insomnia severity ranked by AIS-J), and the χ2 test (other variables). Finally, we examined the significance of the association between SCC occurrence and each variable using logistic regression analysis (forced entry) adapting a model wherein the presence of SCCs was the dependent variable (1: presence, 0: absence) and all other items were independent variables. All the statistical analyses were performed using SPSS Statistics software (version 26, IBM, New York, NY, USA), with a significance level of 5%.

3. Results

In our study, 145 participants had a KCL-CF score of 0, 75 had a score of 1, 19 had a score of 2, and 2 had a score of 3. Accordingly, 39.8% of the participants were evaluated to have SCCs (KCL-CF score ≥ 1). Based on the AIS-J, the insomnia severity was determined to be pathological insomnia (6–24 points) in 34 (14.1%) participants, nocturnal insomnia (4–5 points) in 48 (19.9%) participants, and no insomnia (0–3 points) in 159 (66.0%) participants. Fisher’s exact test results revealed that the participants with SCCs had a significantly higher percentage of severe insomnia (Table 1; p = 0.0004).
Table 2 shows the between-group comparisons of the basic attributes and various measurement items. Compared with the participants without SCCs, those with SCCs were significantly older, had a lower educational level, had higher AIS-J scores, had higher GDS-5 scores, had lower MMSE scores, and a higher proportion of participants had past or current smoking habits (p < 0.05).
Logistic regression analysis (forced entry) was performed with the presence of SCCs as the dependent variable (Table 3). The results indicated that the AIS-J (OR, 1.16; 95% CI, 1.03–1.31; p < 0.05) and having a past or current smoking habit (OR, 3.48, 95% CI, 1.24–9.70, p < 0.05) remained significant explanatory variables after adjusting for various risk factors for dementia.

4. Discussion

In this study, we hypothesized that insomnia symptoms would be associated with the incidence of SCCs among community-dwelling elderly people in Japan. Our findings indicated that the patients with SCCs were significantly older, had a lower educational level, had more severe symptoms of insomnia (AIS-J) and depression (GDS-5), had lower general cognitive function (MMSE), and had a higher proportion of past or current smoking habits than the patients without SCCs. Furthermore, logistic regression analysis with adjustment for various risk factors for dementia demonstrated that severe insomnia was an independent factor associated with the incidence of SCCs.
In our study, the incidence of SCCs (KCL-CF score ≥ 1) was 39.8%, which is higher than previously reported values among community-dwelling older adults in Japan, including rates of 32.5% [28], 34.5% [47], 34.9% [29], 35.4% [48], and 37.6% [49]. This may be attributed to an increase in the incidence of SCCs with age [50]. Compared with participants in previous studies (mean age: 73.3–75.9 years) [28,29,47,48,49], our participants were slightly older (mean age, 77.3 ± 5.9 years), which may have resulted in a higher incidence of SCCs. Taken together, the incidence rate of SCCs in our study was within the expected range based on previously reported values.
Compared with the participants without SCCs, those with SCCs were older, had a lower educational level, had more severe symptoms of insomnia (AIS-J) and depression (GDS-5), had lower general cognitive functioning (MMSE), and a higher proportion of them had past or current smoking habits (Table 2). Furthermore, these items were significantly associated with the presence of SCCs in the single regression analysis (Table 3). Consistent with our findings, previous studies have reported significant differences in the following factors among older adults with SCCs: age [50,51], educational history [52,53], insomnia symptoms [54], depressive symptoms [18], general cognitive functioning [55], and current [56,57] and past [58] smoking habits. Taken together, these findings corroborate the demographic and neurophysiological characteristics of community-dwelling elderly individuals with SCCs in Japan.
Logistic regression analysis with adjustment for several risk factors for dementia revealed that the factors associated with the incidence of SCCs were the severity of insomnia and having a past or current smoking habit (Table 3). Previous studies have reported that insomnia is associated with the development of SCCs [51,54,59,60,61,62,63,64,65,66]. This could be attributed to the disruption of functional connectivity of the major resting-state networks in patients with insomnia [67]. These abnormalities in functional connectivity are associated with SCC severity [68,69,70] and may mediate the effect of sleep disturbances on SCC development. Another contributing factor is the presence of insomnia-induced neuropsychiatric symptoms (NPS), including depression and anxiety [71,72]. The presence of these NPS influences the development of SCCs [73] and may explain the high incidence of SCCs among individuals with insomnia. Furthermore, taking sleeping pills has been reported to be associated with SCCs [74]. Individuals with insomnia symptoms frequently use sleeping pills [75], which may contribute to SCC development. Regarding smoking habits, current and past smoking habits each have an effect on SCC development [56]. Moreover, the risk of SCCs is positively correlated with cumulative exposure to smoking among current or past smokers [58]. Our findings are consistent with these previous reports. The proposed mechanisms through which smoking affects cognitive function include impairment of endothelial function, inhibition of brain oxygen supply, increased oxidative stress, altered mitochondrial energy metabolism, decreased synaptic connectivity, and metabolic enzymes involved in amyloid-β and tau proteins [76]. To this point, SCCs were more likely to occur among the participants who presented with these factors.
Our findings indicated that the development of SCCs in community-dwelling elderly individuals was influenced by insomnia and smoking habits. These factors are both modifiable, treatable, and may be targeted to prevent the development of SCCs among community-dwelling elderly persons.
To this point, the following methods can be applied to the prevention and management of SCCs among community-dwelling elderly persons in Japan:
Addressing sociodemographic conditions (low income, unemployment), poor health behaviors (alcohol consumption, diabetes, hypertension, inactivity, obesity), and mental health conditions (poor subjective health status, stress, depressive symptoms) [77] associated with the development of insomnia and establishing interventions (e.g., meditation, music appreciation) [78] to improve insomnia symptoms
Reducing exposure to smoking and passive smoking by providing health education and environmental improvement recommendations [58].
This study has several limitations. First, given the cross-sectional design, we could not establish a causal relationship. Longitudinal studies are warranted to clarify the relationship between the changes in each indicator and SCC development. Second, we could not collect detailed information regarding the participants’ objective sleep assessment and medication status. Future studies are warranted to provide additional details. Finally, our participants were relatively healthy. It remains unclear whether our findings can be applied to a population with poorer health.
Nonetheless, this study is significant because it suggests that modifiable factors, namely insomnia and smoking habits, may influence SCC development among community-dwelling elderly in Japan.

5. Conclusions

This study examined the association between SCC prevalence and sleep disorders among community-dwelling elderly in Japan. Our findings indicated that SCC prevalence was associated with the severity of sleep disorders and smoking habits. Therefore, geriatricians need to implement measures that target modifiable factors, such as improving sleep disorders and teaching smoking cessation. Despite some limitations, our findings may help healthcare professionals in the field of geriatrics to design and implement more effective intervention programs for preventing dementia in the elderly population.

Author Contributions

Conceptualization, A.G. and S.M.; Data Curation, A.G.; Formal Analysis, A.G.; Funding Acquisition, A.G. and S.M.; Investigation, A.G., H.N., Y.K., K.M., N.M. and S.M.; Methodology, A.G. and S.M.; Resources, H.N., Y.K., N.M. and S.M.; Supervision, S.M.; Writing—Original Draft Preparation, A.G.; Writing—Review and Editing, H.N., Y.K., K.M., N.M. and S.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by JSPS KAKENHI (grant number JP 21H03279) and Hokuriku University Special Research Grant (grant number 2024250103).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Kyoto Tachibana University (accession nos. 18-26 and date of approval 18 July 2018).

Informed Consent Statement

Informed consent was obtained from all the participants involved in this study. Written informed consent has been obtained from the participants to publish this paper.

Data Availability Statement

Qualified researchers can obtain the data presented in this study from the corresponding author.

Conflicts of Interest

Nozomi Mitsumaru is affiliated with Kusukinomori Co., Ltd. The remaining authors declare no conflicts of interest.

References

  1. The Lancet Regional Health Europe. Challenges for addressing dementia. Lancet Reg. Health Eur. 2022, 20, 100504. [Google Scholar] [CrossRef]
  2. Nichols, E.; Steinmetz, J.D.; Vollset, S.E.; Fukutaki, K.; Chalek, J.; Abd-Allah, F.; Abdoli, A.; Abualhasan, A.; Abu-Gharbieh, E.; Akram, T.T.; et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet Public Health 2022, 7, e105–e125. [Google Scholar] [CrossRef] [PubMed]
  3. Wimo, A.; Seeher, K.; Cataldi, R.; Cyhlarova, E.; Dielemann, J.L.; Frisell, O.; Guerchet, M.; Jönsson, L.; Malaha, A.K.; Nichols, E.; et al. The worldwide costs of dementia in 2019. Alzheimer’s Dement. 2023, 19, 2865–2873. [Google Scholar] [CrossRef]
  4. Niotis, K.; Akiyoshi, K.; Carlton, C.; Isaacson, R. Dementia prevention in clinical practice. Semin. Neurol. 2022, 42, 525–548. [Google Scholar] [CrossRef]
  5. 2022 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2022, 18, 700–789. [CrossRef] [PubMed]
  6. Jessen, F.; Amariglio, R.E.; van Boxtel, M.; Breteler, M.; Ceccaldi, M.; Chételat, G.; Dubois, B.; Dufouil, C.; Ellis, K.A.; van der Flier, W.M.; et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimer’s Dement. 2014, 10, 844–852. [Google Scholar] [CrossRef]
  7. Jacob, L.; Haro, J.M.; Koyanagi, A. Physical multimorbidity and subjective cognitive complaints among adults in the United Kingdom: A cross-sectional community-based study. Sci. Rep. 2019, 9, 12417. [Google Scholar] [CrossRef]
  8. Gómez-Ramírez, J.; Ávila-Villanueva, M.; Fernández-Blázquez, M.Á. Selecting the most important self-assessed features for predicting conversion to mild cognitive impairment with random forest and permutation-based methods. Sci. Rep. 2020, 10, 20630. [Google Scholar] [CrossRef] [PubMed]
  9. Parfenov, V.A.; Zakharov, V.V.; Kabaeva, A.R.; Vakhnina, N.V. Subjective cognitive decline as a predictor of future cognitive decline: A systematic review. Dement. Neuropsychol. 2020, 14, 248–257. [Google Scholar] [CrossRef]
  10. Gordon, B.A.; Blazey, T.M.; Su, Y.; Hari-Raj, A.; Dincer, A.; Flores, S.; Christensen, J.; McDade, E.; Wang, G.; Xiong, C.; et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer’s disease: A longitudinal study. Lancet Neurol. 2018, 17, 241–250. [Google Scholar] [CrossRef]
  11. McDade, E.; Wang, G.; Gordon, B.A.; Hassenstab, J.; Benzinger, T.L.S.; Buckles, V.; Fagan, A.M.; Holtzman, D.M.; Cairns, N.J.; Goate, A.M.; et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology 2018, 91, e1295–e1306. [Google Scholar] [CrossRef]
  12. Yu, X.; Shao, K.; Wan, K.; Li, T.; Li, Y.; Zhu, X.; Han, Y. Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer’s disease. Chin. Med. J. 2023, 136, 505–521. [Google Scholar] [CrossRef]
  13. Walsh, S.; Wallace, L.; Kuhn, I.; Mytton, O.; Lafortune, L.; Wills, W.; Mukadam, N.; Brayne, C. Population-level interventions for the primary prevention of dementia: A complex evidence review. Lancet 2023, 402 (Suppl. S1), S13. [Google Scholar] [CrossRef] [PubMed]
  14. Ismail, Z.; Black, S.E.; Camicioli, R.; Chertkow, H.; Herrmann, N.; Laforce, R., Jr.; Montero-Odasso, M.; Rockwood, K.; Rosa-Neto, P.; Seitz, D.; et al. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Alzheimer’s Dement. 2020, 16, 1182–1195. [Google Scholar] [CrossRef]
  15. Nakakubo, S.; Doi, T.; Makizako, H.; Tsutsumimoto, K.; Hotta, R.; Kurita, S.; Kim, M.; Suzuki, T.; Shimada, H. Sleep condition and cognitive decline in Japanese community-dwelling older people: Data from a 4-year longitudinal study. J. Sleep Res. 2019, 28, e12803. [Google Scholar] [CrossRef]
  16. Gaur, A.; Kaliappan, A.; Balan, Y.; Sakthivadivel, V.; Medala, K.; Umesh, M. Sleep and Alzheimer: The link. Maedica 2022, 17, 177–185. [Google Scholar] [CrossRef] [PubMed]
  17. McKinnon, A.C.; Beath, A.P.; Naismith, S.L. Relationships between sleep quality, depressive symptoms and MCI diagnosis: A path analysis. J. Affect. Disord. 2019, 256, 26–32. [Google Scholar] [CrossRef] [PubMed]
  18. Jiang, H.X.; Xie, X.; Xu, Y.; Wang, R.; Lei, X.; Yu, J. Older adults’ subjective cognitive decline correlated with subjective but not objective sleep: A mediator role of depression. Int. J. Aging Hum. Dev. 2022, 95, 42–56. [Google Scholar] [CrossRef]
  19. Ikeda, Y.; Tabira, T.; Ohshige, T.; Masumitsu, T.; Makizako, H.; Ku-Ohl Project Member. Association between sleep onset problem and subjective cognitive complaints among Japanese older adults during the coronavirus disease 2019 pandemic. Int. J. Environ. Res. Public Health 2022, 20, 156. [Google Scholar] [CrossRef]
  20. Röhr, S.; Pabst, A.; Riedel-Heller, S.G.; Jessen, F.; Turana, Y.; Handajani, Y.S.; Brayne, C.; Matthews, F.E.; Stephan, B.C.M.; Lipton, R.B.; et al. Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: A COSMIC study. Alzheimer’s Res. Ther. 2020, 12, 167. [Google Scholar] [CrossRef]
  21. Sugishita, M.; Hemmi, I.; Takeuchi, T. Reexamination of the validity and reliability of the Japanese version of the Mini-Mental State Examination (MMSE-J). Jpn. J. Cogn. Neurosci. 2016, 18, 168–183. [Google Scholar]
  22. Folstein, M.F.; Folstein, S.E.; McHugh, P.R. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12, 189–198. [Google Scholar] [CrossRef] [PubMed]
  23. Ideno, Y.; Takayama, M.; Hayashi, K.; Takagi, H.; Sugai, Y. Evaluation of a Japanese version of the Mini-Mental State Examination in elderly persons. Geriatr. Gerontol. Int. 2012, 12, 310–316. [Google Scholar] [CrossRef] [PubMed]
  24. Hirose, J.; Taniwaki, T.; Usuku, K.; Oka, K.; Mizuta, H.; Nagata, T.; Tomiguchi, W.; Ogushi, M.; Koga, H.; Okamoto, N.; et al. Validation of each category of Kihon checklist for assessing physical functioning, nutrition and cognitive status in a community-dwelling older Japanese cohort. Epidemiology 2017, 7, 326. [Google Scholar]
  25. Satake, S.; Senda, K.; Hong, Y.J.; Miura, H.; Endo, H.; Sakurai, T.; Kondo, I.; Toba, K. Validity of the Kihon Checklist for assessing frailty status. Geriatr. Gerontol. Int. 2016, 16, 709–715. [Google Scholar] [CrossRef] [PubMed]
  26. Sewo Sampaio, P.Y.; Sampaio, R.A.C.; Yamada, M.; Arai, H. Systematic review of the Kihon Checklist: Is it a reliable assessment of frailty? Geriatr. Gerontol. Int. 2016, 16, 893–902. [Google Scholar] [CrossRef] [PubMed]
  27. Tomata, Y.; Sugiyama, K.; Kaiho, Y.; Sugawara, Y.; Hozawa, A.; Tsuji, I. Predictive ability of a simple subjective memory complaints scale for incident dementia: Evaluation of Japan’s national checklist, the “Kihon Checklist”. Geriatr. Gerontol. Int. 2017, 17, 1300–1305. [Google Scholar] [CrossRef] [PubMed]
  28. Okura, M.; Ogita, M.; Arai, H. Self-reported cognitive frailty predicts adverse health outcomes for community-dwelling older adults based on an analysis of sex and age. J. Nutr. Health Aging 2019, 23, 654–664. [Google Scholar] [CrossRef] [PubMed]
  29. Nemoto, Y.; Sato, S.; Takahashi, M.; Takeda, N.; Matsushita, M.; Kitabatake, Y.; Maruo, K.; Arao, T. The association of single and combined factors of sedentary behavior and physical activity with subjective cognitive complaints among community-dwelling older adults: Cross-sectional study. PLoS ONE 2018, 13, e0195384. [Google Scholar] [CrossRef]
  30. Okajima, I.; Nakajima, S.; Kobayashi, M.; Inoue, Y. Development and validation of the Japanese version of the Athens Insomnia Scale. Psychiatry Clin. Neurosci. 2013, 67, 420–425. [Google Scholar] [CrossRef]
  31. Enomoto, K.; Adachi, T.; Yamada, K.; Inoue, D.; Nakanishi, M.; Nishigami, T.; Shibata, M. Reliability and validity of the Athens Insomnia Scale in chronic pain patients. J. Pain Res. 2018, 11, 793–801. [Google Scholar] [CrossRef] [PubMed]
  32. Hoyl, M.T.; Alessi, C.A.; Harker, J.O.; Josephson, K.R.; Pietruszka, F.M.; Koelfgen, M.; Mervis, J.R.; Fitten, L.J.; Rubenstein, L.Z. Development and testing of a five-item version of the Geriatric Depression Scale. J. Am. Geriatr. Soc. 1999, 47, 873–878. [Google Scholar] [CrossRef] [PubMed]
  33. Wada, Y.; Murata, C.; Hirai, H.; Kondo, N.; Kondo, K.; Ueda, K.; Ichida, N. Predictive validity of GDS5 using AGES project data. Kousei Shihyou 2014, 61, 7–12. (In Japanese) [Google Scholar]
  34. Niu, H.; Álvarez-Álvarez, I.; Guillén-Grima, F.; Aguinaga-Ontoso, I. Prevalence and incidence of Alzheimer’s disease in Europe: A meta-analysis. Neurologia 2017, 32, 523–532. [Google Scholar] [CrossRef] [PubMed]
  35. Daviglus, M.L.; Bell, C.C.; Berrettini, W.; Bowen, P.E.; Connolly, E.S., Jr.; Cox, N.J.; Dunbar-Jacob, J.M.; Granieri, E.C.; Hunt, G.; McGarry, K.; et al. National Institutes of Health State-of-the-Science Conference statement: Preventing alzheimer disease and cognitive decline. Ann. Intern. Med. 2010, 153, 176–181. [Google Scholar] [CrossRef] [PubMed]
  36. Van Patten, R.; Tremont, G. Public knowledge of late-life cognitive decline and dementia in an international sample. Dementia 2020, 19, 1758–1776. [Google Scholar] [CrossRef] [PubMed]
  37. Sierra, C. Hypertension and the risk of dementia. Front. Cardiovasc. Med. 2020, 7, 5. [Google Scholar] [CrossRef] [PubMed]
  38. Cholerton, B.; Baker, L.D.; Montine, T.J.; Craft, S. Type 2 diabetes, cognition, and dementia in older adults: Toward a precision health approach. Diabetes Spectr. 2016, 29, 210–219. [Google Scholar] [CrossRef] [PubMed]
  39. Zhu, Y.; Liu, X.; Zhu, R.; Zhao, J.; Wang, Q. Lipid levels and the risk of dementia: A dose-response meta-analysis of prospective cohort studies. Ann. Clin. Transl. Neurol. 2022, 9, 296–311. [Google Scholar] [CrossRef]
  40. Jia, R.; Wang, Q.; Huang, H.; Yang, Y.; Chung, Y.F.; Liang, T. Cardiovascular disease risk models and dementia or cognitive decline: A systematic review. Front. Aging Neurosci. 2023, 15, 1257367. [Google Scholar] [CrossRef]
  41. Myrstad, C.; Engdahl, B.L.; Costafreda, S.G.; Krokstad, S.; Lin, F.; Livingston, G.; Strand, B.H.; Øhre, B.; Selbæk, G. Hearing impairment and risk of dementia in the HUNT Study (HUNT4 70+): A Norwegian cohort study. EClinicalMedicine 2023, 66, 102319. [Google Scholar] [CrossRef] [PubMed]
  42. Gu, D.; Ou, S.; Liu, G. Traumatic brain injury and risk of dementia and Alzheimer’s disease: A systematic review and meta-analysis. Neuroepidemiology 2022, 56, 4–16. [Google Scholar] [CrossRef] [PubMed]
  43. Wiegmann, C.; Mick, I.; Brandl, E.J.; Heinz, A.; Gutwinski, S. Alcohol and dementia—What is the link? A systematic review. Neuropsychiatr. Dis. Treat. 2020, 16, 87–99. [Google Scholar] [CrossRef] [PubMed]
  44. Ohara, T.; Ninomiya, T.; Hata, J.; Ozawa, M.; Yoshida, D.; Mukai, N.; Nagata, M.; Iwaki, T.; Kitazono, T.; Kanba, S.; et al. Midlife and late-life smoking and risk of dementia in the community: The Hisayama study. J. Am. Geriatr. Soc. 2015, 63, 2332–2339. [Google Scholar] [CrossRef] [PubMed]
  45. Guarnera, J.; Yuen, E.; Macpherson, H. The impact of loneliness and social isolation on cognitive aging: A narrative review. J. Alzheimer’s Dis. Rep. 2023, 7, 699–714. [Google Scholar] [CrossRef] [PubMed]
  46. Wang, S.; Liu, H.Y.; Cheng, Y.C.; Su, C.H. Exercise dosage in reducing the risk of dementia development: Mode, duration, and intensity-A narrative review. Int. J. Environ. Res. Public Health 2021, 18, 13331. [Google Scholar] [CrossRef] [PubMed]
  47. Okura, M.; Ogita, M.; Yamamoto, M.; Nakai, T.; Numata, T.; Arai, H. The relationship of community activities with cognitive impairment and depressive mood independent of mobility disorder in Japanese older adults. Arch. Gerontol. Geriatr. 2017, 70, 54–61. [Google Scholar] [CrossRef] [PubMed]
  48. Goda, A.; Murata, S.; Nakano, H.; Shiraiwa, K.; Abiko, T.; Nonaka, K.; Iwase, H.; Anami, K.; Horie, J. Subjective and objective mental and physical functions affect subjective cognitive decline in community-dwelling elderly Japanese people. Healthcare 2020, 8, 347. [Google Scholar] [CrossRef] [PubMed]
  49. Tomata, Y.; Sugiyama, K.; Kaiho, Y.; Honkura, K.; Watanabe, T.; Zhang, S.; Sugawara, Y.; Tsuji, I. Green tea consumption and the risk of incident dementia in elderly Japanese: The Ohsaki cohort 2006 study. Am. J. Geriatr. Psychiatry 2016, 24, 881–889. [Google Scholar] [CrossRef]
  50. Wen, C.; Hu, H.; Ou, Y.N.; Bi, Y.L.; Ma, Y.H.; Tan, L.; Yu, J.T. Risk factors for subjective cognitive decline: The CABLE study. Transl. Psychiatry 2021, 11, 576. [Google Scholar] [CrossRef]
  51. Wei, Y.C.; Huang, L.Y.; Chen, C.K.; Lin, C.; Shyu, Y.C.; Chen, Y.L.; Huang, W.Y.; Lin, C.P. Subjective cognitive decline in the community is affected at multiple aspects of mental health and life quality: A cross-sectional study of the community medicine of Keelung Chang Gung Memorial Hospital. Dement. Geriatr. Cogn. Dis. Extra 2019, 9, 152–162. [Google Scholar] [CrossRef] [PubMed]
  52. Peterson, R.L.; Carvajal, S.C.; McGuire, L.C.; Fain, M.J.; Bell, M.L. State inequality, socioeconomic position and subjective cognitive decline in the United States. SSM Popul. Health 2019, 7, 100357. [Google Scholar] [CrossRef] [PubMed]
  53. Jansen, M.G.; Geerligs, L.; Claassen, J.A.H.R.; Overdorp, E.J.; Brazil, I.A.; Kessels, R.P.C.; Oosterman, J.M. Positive effects of education on cognitive functioning depend on clinical status and neuropathological severity. Front. Hum. Neurosci. 2021, 15, 723728. [Google Scholar] [CrossRef] [PubMed]
  54. Xu, W.Q.; Lin, L.H.; Ding, K.R.; Ke, Y.F.; Huang, J.H.; Hou, C.L.; Jia, F.J.; Wang, S.B. The role of depression and anxiety in the relationship between poor sleep quality and subjective cognitive decline in Chinese elderly: Exploring parallel, serial, and moderated mediation. J. Affect. Disord. 2021, 294, 464–471. [Google Scholar] [CrossRef] [PubMed]
  55. Zullo, L.; Clark, C.; Gholam, M.; Castelao, E.; von Gunten, A.; Preisig, M.; Popp, J. Factors associated with subjective cognitive decline in dementia-free older adults-A population-based study. Int. J. Geriatr. Psychiatry 2021, 36, 1188–1196. [Google Scholar] [CrossRef] [PubMed]
  56. Rajczyk, J.I.; Ferketich, A.; Wing, J.J. Relation between smoking status and subjective cognitive decline in middle age and older adults: A cross-sectional analysis of 2019 behavioral risk factor surveillance system data. J. Alzheimer’s Dis. 2023, 91, 215–223. [Google Scholar] [CrossRef] [PubMed]
  57. Joo, H.J.; Joo, J.H.; Kwon, J.; Jang, B.N.; Park, E.C. Association between quality and duration of sleep and subjective cognitive decline: A cross-sectional study in South Korea. Sci. Rep. 2021, 11, 16989. [Google Scholar] [CrossRef] [PubMed]
  58. Kim, J.H.; Chang, I.B.; Kim, Y.H.; Min, C.Y.; Yoo, D.M.; Choi, H.G. Association between various types or statuses of smoking and subjective cognitive decline based on a community health survey of Korean adults. Front. Neurol. 2022, 13, 810830. [Google Scholar] [CrossRef] [PubMed]
  59. Exalto, L.G.; Hendriksen, H.M.A.; Barkhof, F.; van den Bosch, K.A.; Ebenau, J.L.; van Leeuwenstijn-Koopman, M.; Prins, N.D.; Teunissen, C.E.; Visser, L.N.C.; Scheltens, P.; et al. Subjective cognitive decline and self-reported sleep problems: The SCIENCe project. Alzheimer’s Dement. 2022, 14, e12287. [Google Scholar] [CrossRef]
  60. Kim, J.H.; Ahn, J.H.; Min, C.Y.; Yoo, D.M.; Choi, H.G. Association between sleep quality and subjective cognitive decline: Evidence from a community health survey. Sleep Med. 2021, 83, 123–131. [Google Scholar] [CrossRef]
  61. Kim, M.; Lim, K.C.; Ko, H. Factors influencing subjective cognitive function among community-dwelling older adults. Geriatr. Nurs. 2021, 42, 1070–1076. [Google Scholar] [CrossRef] [PubMed]
  62. Lee, J.E.; Ju, Y.J.; Park, E.C.; Lee, S.Y. Effect of poor sleep quality on subjective cognitive decline (SCD) or SCD-related functional difficulties: Results from 220,000 nationwide general populations without dementia. J. Affect. Disord. 2020, 260, 32–37. [Google Scholar] [CrossRef] [PubMed]
  63. Leng, M.; Yin, H.; Zhang, P.; Jia, Y.; Hu, M.; Li, G.; Wang, C.; Chen, L. Sleep quality and health-related quality of life in older people with subjective cognitive decline, mild cognitive impairment, and Alzheimer disease. J. Nerv. Ment. Dis. 2020, 208, 387–396. [Google Scholar] [CrossRef] [PubMed]
  64. Lin, L.H.; Wang, S.B.; Xu, W.Q.; Hu, Q.; Zhang, P.; Ke, Y.F.; Huang, J.H.; Ding, K.R.; Li, X.L.; Hou, C.L.; et al. Subjective cognitive decline symptoms and its association with socio-demographic characteristics and common chronic diseases in the southern Chinese older adults. BMC Public Health 2022, 22, 127. [Google Scholar] [CrossRef] [PubMed]
  65. Wardle-Pinkston, S.; Slavish, D.C.; Taylor, D.J. Insomnia and cognitive performance: A systematic review and meta-analysis. Sleep Med. Rev. 2019, 48, 101205. [Google Scholar] [CrossRef] [PubMed]
  66. Winer, J.R.; Deters, K.D.; Kennedy, G.; Jin, M.; Goldstein-Piekarski, A.; Poston, K.L.; Mormino, E.C. Association of short and long sleep duration with amyloid-β burden and cognition in aging. JAMA Neurol. 2021, 78, 1187–1196. [Google Scholar] [CrossRef] [PubMed]
  67. Fasiello, E.; Gorgoni, M.; Scarpelli, S.; Alfonsi, V.; Ferini Strambi, L.; De Gennaro, L. Functional connectivity changes in insomnia disorder: A systematic review. Sleep Med. Rev. 2022, 61, 101569. [Google Scholar] [CrossRef]
  68. Sharma, N.; Murari, G.; Vandermorris, S.; Verhoeff, N.P.L.G.; Herrmann, N.; Chen, J.J.; Mah, L. Functional connectivity between the posterior default mode network and parahippocampal gyrus is disrupted in older adults with subjective cognitive decline and correlates with subjective memory ability. J. Alzheimer’s Dis. 2021, 82, 435–445. [Google Scholar] [CrossRef]
  69. Viviano, R.P.; Damoiseaux, J.S. Longitudinal change in hippocampal and dorsal anterior insulae functional connectivity in subjective cognitive decline. Alzheimer’s Res. Ther. 2021, 13, 108. [Google Scholar] [CrossRef]
  70. Wang, S.; Sun, H.; Hu, G.; Xue, C.; Qi, W.; Rao, J.; Zhang, F.; Zhang, X.; Chen, J. Altered insular subregional connectivity associated with cognitions for distinguishing the spectrum of pre-clinical Alzheimer’s disease. Front. Aging Neurosci. 2021, 13, 597455. [Google Scholar] [CrossRef]
  71. Winkelman, J.W.; Lecea, L. Sleep and neuropsychiatric illness. Neuropsychopharmacology 2020, 45, 1–2. [Google Scholar] [CrossRef] [PubMed]
  72. Ford, D.E.; Kamerow, D.B. Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention? JAMA 1989, 262, 1479–1484. [Google Scholar] [CrossRef] [PubMed]
  73. Sannemann, L.; Schild, A.K.; Altenstein, S.; Bartels, C.; Brosseron, F.; Buerger, K.; Cosma, N.C.; Fliessbach, K.; Freiesleben, S.D.; Glanz, W.; et al. Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study. Alzheimer’s Res. Ther. 2020, 12, 131. [Google Scholar] [CrossRef] [PubMed]
  74. Lee, J.E.; Ju, Y.J.; Chun, K.H.; Lee, S.Y. The frequency of sleep medication use and the risk of subjective cognitive decline (SCD) or SCD with functional difficulties in elderly individuals without dementia. J. Gerontol. A Biol. Sci. Med. Sci. 2020, 75, 1693–1698. [Google Scholar] [CrossRef] [PubMed]
  75. Mishima, K.; DiBonaventura, M.D.; Gross, H. The burden of insomnia in Japan. Nat. Sci. Sleep. 2015, 7, 1–11. [Google Scholar] [CrossRef] [PubMed]
  76. Cervilla, J.A.; Prince, M.; Mann, A. Smoking, drinking, and incident cognitive impairment: A cohort community based study included in the Gospel Oak project. J. Neurol. Neurosurg. Psychiatry 2000, 68, 622–626. [Google Scholar] [CrossRef]
  77. Lee, S.Y.; Ju, Y.J.; Lee, J.E.; Kim, Y.T.; Hong, S.C.; Choi, Y.J.; Song, M.K.; Kim, H.Y. Factors associated with poor sleep quality in the Korean general population: Providing information from the Korean version of the Pittsburgh Sleep Quality Index. J. Affect. Disord. 2020, 271, 49–58. [Google Scholar] [CrossRef]
  78. Innes, K.E.; Selfe, T.K.; Khalsa, D.S.; Kandati, S. Effects of Meditation versus Music Listening on Perceived Stress, Mood, Sleep, and Quality of Life in Adults with Early Memory Loss: A Pilot randomized controlled trial. J. Alzheimer’s Dis. 2016, 52, 1277–1298. [Google Scholar] [CrossRef]
Figure 1. Flowchart of the selection of the study participants.
Figure 1. Flowchart of the selection of the study participants.
Healthcare 12 01245 g001
Table 1. Group comparison of insomnia severity by Fisher’s exact test.
Table 1. Group comparison of insomnia severity by Fisher’s exact test.
VariableSCCNon-SCC
AIS-JNo insomnia49110
Nocturnal insomnia2721
Pathological insomnia2014
SCC group: KCL-CF score ≥ 1; non-SCC group: KCL-CF score = 0; no insomnia group: AIS-J score = 0–3; nocturnal insomnia group: AIS-J score = 4–5; pathological insomnia group: AIS-J score = 6–24; SCCs, subjective cognitive complaints; AIS-J J, Japanese version of the Athens Insomnia Scale.
Table 2. Between-group comparisons of the basic attributes and various measurement items.
Table 2. Between-group comparisons of the basic attributes and various measurement items.
VariableSCCNon-SCCp-Value
(n = 96)(n = 145)
AttributeAge (yr) 78.25 ± 5.9576.70 ± 5.800.05
Sex: Male/Female (n)19/7720/1250.22
BMI (kg/m2) *22.42 ± 3.4322.48 ± 3.290.72
Educational history (yr) *11.178 ± 2.2311.91 ± 2.410.02
Mental and physical indicatorAIS-J (score) *3.70 ± 3.092.41 ± 2.200.001
GDS-5 (score) *0.95 ± 1.200.52 ± 0.840.004
MMSE (score) *27.88 ± 1.9528.39 ± 1.850.02
Medical visits due to diseaseHypertension: yes/no (n)45/5152/930.09
Diabetes: yes/no (n)10/8616/1290.88
Hyperlipidemia: yes/no (n)13/8334/1110.06
Cerebrovascular disease: yes/no (n)5/915/1400.50
Presence of dementia riskHearing loss: yes/no (n)28/6832/1130.21
History of head injury: yes/no (n)8/886/1390.17
Past or current drinking habits: yes/no (n)27/6939/1060.83
Past or current smoking habits: yes/no (n)23/7313/1320.001
Social isolation: yes/no (n)9/8720/1250.30
Physical inactivity: yes/no (n)28/6768/1140.17
Data are presented as mean ± standard deviation; SCC group: KCL-CF score ≥ 1; non-SCC group: KCL-CF score = 0; χ2 test; : t-test using independent samples; *: Mann–Whitney U test; SCCs, subjective cognitive complaints; n, number; yr, year; BMI, body mass index; kg, kilogram; m, meter; AIS-J, Japanese version of the Athens Insomnia Scale; GDS-5, five-item version of the Geriatric Depression Scale; MMSE, Mini-Mental State Examination.
Table 3. Logistic regression analysis with the presence or absence of SCCs as the dependent variable.
Table 3. Logistic regression analysis with the presence or absence of SCCs as the dependent variable.
VariableUnivariate AnalysisMultivariate Analysis
95% CI for OR 95% CI for OR
ORLowerUpperpORLowerUpperp
AttributeAge (yr) 1.051.001.090.051.030.971.090.37
SexFemale0.650.331.290.220.680.212.230.53
Male1.00 1.00
BMI (kg/m2) 0.990.921.070.890.970.881.060.46
Educational history (yr) 0.870.780.980.020.870.751.000.06
Mental and physical indicatorAIS-J (score) 1.211.091.340.0011.161.031.310.02
GDS-5 (score) 1.521.171.980.0041.330.981.820.07
MMSE (score) 0.870.760.990.040.910.771.070.25
Medical visits due to diseaseHypertensionYes1.580.932.670.091.680.903.160.11
No1.00 1.00
DiabetesYes0.940.412.160.880.880.332.350.80
No1.00 1.00
HyperlipidemiaYes0.510.251.030.060.590.271.280.18
No1.00 1.00
Cerebrovascular diseaseYes1.540.435.460.511.260.285.660.77
No1.00 1.00
Presence of dementia riskHearing lossYes1.450.812.620.210.990.482.030.98
No1.00 1.00
History of head injuryYes2.110.716.270.182.420.658.990.19
No1.00 1.00
Past or current drinking habitsYes1.060.601.890.830.800.371.750.58
No1.00 1.00
Past or current smoking habitsYes3.201.536.690.0013.481.249.700.02
No1.00 1.00
Social isolationYes0.650.281.490.300.480.181.230.12
No1.00 1.00
Physical inactivityYes1.510.842.740.171.550.763.180.23
No1.00 1.00
SCCs, subjective cognitive complaints; OR, odds ratio; CI, confidence interval; yr, year; BMI, body mass index; kg, kilogram; m, meter; AIS-J, Japanese version of the Athens Insomnia Scale; GDS-5, five-item version of the Geriatric Depression Scale; MMSE, Mini-Mental State Examination.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Goda, A.; Nakano, H.; Kikuchi, Y.; Mori, K.; Mitsumaru, N.; Murata, S. Association between Subjective Cognitive Complaints and Sleep Disturbance among Community-Dwelling Elderly Individuals in Japan. Healthcare 2024, 12, 1245. https://doi.org/10.3390/healthcare12131245

AMA Style

Goda A, Nakano H, Kikuchi Y, Mori K, Mitsumaru N, Murata S. Association between Subjective Cognitive Complaints and Sleep Disturbance among Community-Dwelling Elderly Individuals in Japan. Healthcare. 2024; 12(13):1245. https://doi.org/10.3390/healthcare12131245

Chicago/Turabian Style

Goda, Akio, Hideki Nakano, Yuki Kikuchi, Kohei Mori, Nozomi Mitsumaru, and Shin Murata. 2024. "Association between Subjective Cognitive Complaints and Sleep Disturbance among Community-Dwelling Elderly Individuals in Japan" Healthcare 12, no. 13: 1245. https://doi.org/10.3390/healthcare12131245

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop